SignatureFD’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $282K | Sell |
4,024
-232
| -5% | -$12K | ﹤0.01% | 932 |
|
|
2026
Q1 | $216K | Buy |
4,256
+965
| +29% | +$45K | ﹤0.01% | 965 |
|
|
2025
Q4 | $97K | Sell |
3,291
-2,137
| -39% | -$58.1K | ﹤0.01% | 1338 |
|
|
2025
Q3 | $140K | Sell |
5,428
-523
| -9% | -$14.6K | ﹤0.01% | 1117 |
|
|
2025
Q2 | $164K | Buy |
5,951
+997
| +20% | +$26.3K | ﹤0.01% | 1007 |
|
|
2025
Q1 | $140K | Buy |
4,954
+1,336
| +37% | +$47.4K | ﹤0.01% | 1051 |
|
|
2024
Q4 | $150K | Buy |
3,618
+535
| +17% | +$25.6K | ﹤0.01% | 1012 |
|
|
2024
Q3 | $206K | Sell |
3,083
-3,605
| -54% | -$331K | ﹤0.01% | 848 |
|
|
2024
Q2 | $794K | Buy |
6,688
+1,579
| +31% | +$200K | 0.02% | 369 |
|
|
2024
Q1 | $544K | Buy |
5,109
+1,528
| +43% | +$154K | 0.01% | 478 |
|
|
2023
Q4 | $356K | Sell |
3,581
-502
| -12% | -$42.2K | 0.01% | 583 |
|
|
2023
Q3 | $422K | Buy |
4,083
+824
| +25% | +$91.9K | 0.01% | 497 |
|
|
2023
Q2 | $396K | Sell |
3,259
-253
| -7% | -$33.8K | 0.01% | 520 |
|
|
2023
Q1 | $539K | Sell |
3,512
-773
| -18% | -$128K | 0.01% | 402 |
|
|
2022
Q4 | $770K | Buy |
4,285
+1,410
| +49% | +$231K | 0.02% | 281 |
|
|
2022
Q3 | $340K | Sell |
2,875
-1,212
| -30% | -$184K | 0.01% | 500 |
|
|
2022
Q2 | $584K | Buy |
4,087
+384
| +10% | +$54.9K | 0.02% | 330 |
|
|
2022
Q1 | $638K | Buy |
3,703
+522
| +16% | +$87.9K | 0.02% | 330 |
|
|
2021
Q4 | $808K | Sell |
3,181
-631
| -17% | -$184K | 0.02% | 256 |
|
|
2021
Q3 | $1.47M | Buy |
3,812
+1,386
| +57% | +$511K | 0.05% | 131 |
|
|
2021
Q2 | $570K | Buy |
2,426
+399
| +20% | +$71.3K | 0.02% | 315 |
|
|
2021
Q1 | $265K | Buy |
2,027
+642
| +46% | +$93K | 0.01% | 488 |
|
|
2020
Q4 | $145K | Buy |
1,385
+716
| +107% | +$72.4K | 0.01% | 644 |
|
|
2020
Q3 | $47K | Buy |
669
+469
| +235% | +$32.7K | ﹤0.01% | 1016 |
|
|
2020
Q2 | $13K | Buy |
200
+146
| +270% | +$8K | ﹤0.01% | 1477 |
|
|
2020
Q1 | $2K | Buy |
+54
| New | +$1.24K | ﹤0.01% | 1971 |
|
|
2019
Q3 | – | Sell |
-2
| Closed | – | – | 2164 |
|
|
2019
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 2118 |
|
|
2019
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 2024 |
|
|
2018
Q4 | $0 | Buy |
+2
| New | +$33 | ﹤0.01% | 2021 |
|
Other funds holding MRNA
TP
SignatureFD's MRNA Position: Q2 2026 in Review
SignatureFD reduced its Moderna (MRNA) stake by 5.5% in Q2 2026, selling an estimated $12K and leaving 4,024 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #932.
SignatureFD first reported a position in MRNA in Q4 2018 and has held it in 29 quarters since. The position peaked at $1.47M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- SignatureFD held 4,024 shares of Moderna worth $282K as of Q2 2026.
- SignatureFD sold 232 Moderna shares in Q2 2026, an estimated $12K.
- Moderna made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #932 holding.
- SignatureFD first reported a position in Moderna in Q4 2018 and has held it in 29 quarters since.
- SignatureFD's Moderna position peaked at $1.47M in Q3 2021.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.